血清血管内皮生长因子对POEMS综合征的早期诊断

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (548 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the significance of serum VEGF (vascular endothelial growth factor) in the differential diagnosis between POEMS syndrome and peripheral neuropathy, and the value of detection of VEGF in the early diagnosis of POEMS syndrome. Methods 30 patients were collected in PLA General Hospital from June 2012 to June 2014.18 patients were diagnosed as having POEMS syndrome in the study group and 12 patients diagnosed as having peripheral neuropathy in as the control group. All of them underwent the detection of serum VEGF levels. Results The data displayed that the mean concentration of VEGF in POEMS syndrome group, (687.85±179.07) pg/ml (4.8 times of normal value), was higher than that in the control group,(301.07±112.53)pg/l (2.1 times of normal value); there was a statistically significant difference between the two groups (t=5.783, P<0.01). The diagnostic area under curve (AUC) was 0. 970, cut-off value was 409.33 pg/ml, sensitivity was 1.000, specificity was 0.800, and accuracy was 0.968 respectively. Conclusions VEGF is a very important serological marker of POEMS syndrome. It is helpful for the differential diagnosis of POEMS syndrome and other peripheral neuropathy. The elevated level of serum VEGF value may be meaningful for the diagnosis of the disease, the high VEGF value supports the diagnosis of POEMS syndrome.

Key words： POEMS syndrome vascular endothelial growth factor peripheral neuropathy

Received: 16 June 2015

ZTFLH:

R541.6

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MA Lina
	YU Shengyuan
	LIU Ruozhuo
	and FU Xitao

Cite this article:

MA Lina,YU Shengyuan,LIU Ruozhuo等. Detection of serum VEGF is useful for early diagnosis of POEMS syndrome[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2015, 26(12): 1210-1212.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2015/V26/I12/1210

[1]	Dispenzieri A. How I treat POEMS syndrome[J]. Blood, 2012,119(24):5650-5658.
[2]	Dispenzieri A. POEMS syndrome[J]. Blood Rev, 2007,21(6):285-299.
[1]	Dispenzieri A. How I treat POEMS syndrome[J]. Blood, 2012,119(24):5650-5658.
[3]	Li J, Zhou D B, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China[J]. Ann Hematol, 2011,90(7):819-826.
[2]	Dispenzieri A. POEMS syndrome[J]. Blood Rev, 2007,21(6):285-299.
[3]	Li J, Zhou D B, Huang Z, et al. Clinical characteristics and long-term outcome of patients with POEMS syndrome in China[J]. Ann Hematol, 2011,90(7):819-826.
[4]	Dispenzieri A, Kyle R A, Lacy M Q, et al. POEMS syndrome: definitions and long-term outcome[J]. Blood, 2003,101(7):2496-2506.
[4]	Dispenzieri A, Kyle R A, Lacy M Q, et al. POEMS syndrome: definitions and long-term outcome[J]. Blood, 2003,101(7):2496-2506.
[5]	Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2011,86(7):591-601.
[5]	Dispenzieri A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2011,86(7):591-601.
[6]	Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2014,89(2):214-223.
[7]	Cui R T, Huang X S, Shi Q, et al. POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China[J]. Intern Med J, 2011,41(6):481-485.
[6]	Dispenzieri A. POEMS syndrome: 2014 update on diagnosis, risk-stratification, and management[J]. Am J Hematol, 2014,89(2):214-223.
[8]	Imai N, Taguchi J, Yagi N, et al. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation[J]. Neuromuscul Disord, 2009,19(5):363-365.
[7]	Cui R T, Huang X S, Shi Q, et al. POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein and skin changes) syndrome in China[J]. Intern Med J, 2011,41(6):481-485.
[9]	D’Souza A, Hayman S R, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome[J]. Blood, 2011,118(17):4663-4665.
[8]	Imai N, Taguchi J, Yagi N, et al. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation[J]. Neuromuscul Disord, 2009,19(5):363-365.
[9]	D’Souza A, Hayman S R, Buadi F, et al. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome[J]. Blood, 2011,118(17):4663-4665.
[10]	Lee J, Huprikar S, Jenkins S G. Are patients with POEMS syndrome at increased risk of salmonella aortitis[J]. Int J Infect Dis, 2009,13(3):e97-99.
[11]	Cui R T, Yu S Y, Huang X S, et al. The characteristics of ascites in patients with POEMS syndrome[J]. Ann Hematol, 2013,92(12):1661-1664.
[12]	叶湘湘,陈中山,丁琴,等.VEGF基因RNA干扰质粒的构建与鉴定[J].华南国防医学杂志,2013,27(5):233-235.
[10]	Lee J, Huprikar S, Jenkins S G. Are patients with POEMS syndrome at increased risk of salmonella aortitis[J]. Int J Infect Dis, 2009,13(3):e97-99.
[11]	Cui R T, Yu S Y, Huang X S, et al. The characteristics of ascites in patients with POEMS syndrome[J]. Ann Hematol, 2013,92(12):1661-1664.
[12]	叶湘湘,陈中山,丁琴,等.VEGF基因RNA干扰质粒的构建与鉴定[J].华南国防医学杂志,2013,27(5):233-235.